Atara Biotherapeutics, Inc.

Research Atara Biotherapeutics, Inc. (0HIY) with Bullrun company financials, valuation charts, model signals, and historical stock context.

Key Metrics

• Ticker0HIY
• ExchangeLSE
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD

About Atara Biotherapeutics, Inc.

Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and internationally. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) with post-transplant lymphoproliferative disease, as well as other EBV-driven diseases.

Frequently asked questions

What does Atara Biotherapeutics, Inc. do?

Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and internationally.